What is the recommended treatment for a gout flare?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Gout Flares

The recommended first-line treatment for an acute gout flare is colchicine 1.2 mg (two 0.6 mg tablets) at the first sign of the flare followed by 0.6 mg (one tablet) one hour later, for a maximum total dose of 1.8 mg over a one-hour period. 1, 2

First-Line Treatment Options

Colchicine

  • Start with 1.2 mg (two tablets) at first sign of flare, followed by 0.6 mg (one tablet) one hour later 1, 2
  • Maximum dose: 1.8 mg over a one-hour period
  • Most effective when started within the first 12-24 hours of symptom onset
  • If a patient is already on prophylactic colchicine when a flare occurs:
    • Administer 1.2 mg at first sign of flare, followed by 0.6 mg one hour later
    • Wait 12 hours before resuming prophylactic dose 1

NSAIDs

  • Full anti-inflammatory doses of NSAIDs are an effective alternative 1, 3
  • Examples include:
    • Naproxen 500 mg twice daily
    • Indomethacin 50 mg three times daily
  • Continue until flare resolves (typically 5-7 days)
  • Caution: Avoid in patients with cardiovascular disease, heart failure, or renal impairment 1, 4

Corticosteroids

  • As effective as NSAIDs with potentially fewer adverse effects 1
  • Options include:
    • Oral prednisone/prednisolone 35 mg daily for 5 days 1
    • Intra-articular injection for monoarticular flares 1
  • Particularly useful in patients with contraindications to colchicine or NSAIDs

Special Considerations

Renal Impairment

  • For mild to moderate renal impairment (CrCl 30-80 mL/min):
    • Standard colchicine dosing can be used with close monitoring 2
  • For severe renal impairment (CrCl <30 mL/min):
    • Avoid colchicine and NSAIDs
    • Use corticosteroids as first-line therapy 1, 2
    • If colchicine must be used, treatment course should not be repeated more than once every two weeks 2
  • For patients on dialysis:
    • Reduce colchicine to a single dose of 0.6 mg
    • Do not repeat treatment more than once every two weeks 2

Cardiovascular Disease

  • Colchicine is considered safe and may potentially reduce the risk of myocardial infarction 4
  • Avoid NSAIDs due to increased cardiovascular risk 1, 4
  • Short courses of low-dose corticosteroids are a reasonable alternative 4

Hepatic Impairment

  • For mild to moderate hepatic impairment:
    • Standard colchicine dosing with close monitoring 2
  • For severe hepatic impairment:
    • Standard colchicine dosing but do not repeat treatment more than once every two weeks 2
    • Consider alternative therapy for repeated flares

Drug Interactions

  • Colchicine has significant interactions with strong CYP3A4 inhibitors and P-glycoprotein inhibitors 1, 2
  • Examples include clarithromycin, ketoconazole, ritonavir
  • Dose adjustment required when used with these medications 2

Combination Therapy

For severe, multiarticular gout flares, combination therapy may be considered:

  • Colchicine plus NSAID
  • Colchicine plus corticosteroid 1

Prevention of Future Flares

After treating the acute flare, consider:

  • Prophylactic therapy when starting urate-lowering treatment (ULT)

    • Low-dose colchicine (0.6 mg once or twice daily)
    • Low-dose NSAIDs
    • Continue for 3-6 months after starting ULT 1, 5
  • Long-term ULT should be considered for:

    • Patients with radiographic damage attributable to gout
    • Frequent gout flares (>2/year)
    • Presence of tophi
    • CKD stage >3, serum urate >9 mg/dl, or urolithiasis 6
  • First-line ULT is allopurinol, starting at ≤100 mg/day with gradual dose titration 6, 1

Common Pitfalls to Avoid

  • Delaying treatment - efficacy decreases with delayed initiation
  • Using high-dose colchicine regimens - these cause significant gastrointestinal side effects
  • Discontinuing ULT during acute flares - this can worsen and prolong the flare
  • Not providing prophylaxis when initiating ULT - this increases risk of flares
  • Not addressing underlying hyperuricemia after treating acute flares - this leads to recurrent attacks

Remember that early intervention with appropriate therapy is crucial for effective management of gout flares and prevention of future attacks.

References

Guideline

Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Non-steroidal anti-inflammatory drugs for acute gout.

The Cochrane database of systematic reviews, 2021

Research

Pharmacologic Management of Gout in Patients with Cardiovascular Disease and Heart Failure.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.